NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.

Physicians and other health care providers are finding molecular diagnostics to be a useful part of their practice, and the number of genetic tests available continues to grow at a rapid pace.

Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...

The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia Department of Pathology is now offering a new coronavirus test with expanded capacity to the entire state. "We have ...

Enhancing network integration and quality through implementation of a general medical oncology tumor board and disease management group.

SIOUX CITY - Siouxland women can now benefit from a new molecular genetic testing lab opened by Sioux City physicians that will test patient DNA for certain viruses and diseases. The Molecular Lab of ...